Showing results (2201-2210 of 3,160) with videos related to
Sort By:
Pageof 316
Neuro-Oncology|January 26, 2026
Integrated immune profiling of chordomas reveals spatially organized niches and functional heterogeneityVictor A Arrieta, J Kada Benotmane, Rebecca Du, et al.Neuro-Oncology|January 20, 2026
Ibrutinib in combination with rituximab, methotrexate, vincristine, and procarbazine (R-MVP/i) for newly diagnosed primary CNS lymphoma (PCNSL)Lauren R Schaff, Elena Pentsova, Rachna Malani, et al.Neuro-Oncology|January 8, 2026
Trastuzumab deruxtecan efficacy, FcRn-facilitated penetration of the blood-tumor barrier and distribution to tumor cells in HER2+ brain metastasis model systemsImran Khan, Dinesh Kumar, Wei Zhang, et al.Neuro-Oncology|February 22, 2023
Nivolumab with or without ipilimumab in pediatric patients with high-grade CNS malignancies: Safety, efficacy, biomarker, and pharmacokinetics-CheckMate 908Ira J Dunkel, François Doz, Nicholas K Foreman, et al.Neuro-Oncology|August 22, 2025
Clinical, Radiological, and Molecular Insights into Extracranial Metastases from Adult GliomasJulie Jacobsen, Alessio Locallo, Colm J O'Rourke, et al.Neuro-Oncology|February 3, 2023
Whole-brain radiotherapy associated with structural changes resembling aging as determined by anatomic surface-based deep learningNikhil Rammohan, Alexander Ho, Pierre Besson, et al.Neuro-Oncology|January 30, 2023
Risk prediction in early childhood sonic hedgehog medulloblastoma treated with radiation-avoiding chemotherapy: Evidence for more than 2 subgroupsSvenja Tonn, Andrey Korshunov, Denise Obrecht, et al.Neuro-Oncology|January 27, 2023
Novel murine glioblastoma models that reflect the immunotherapy resistance profile of a human diseaseChao-Hsien Chen, Renee L Chin, Genevieve P Hartley, et al.Neuro-Oncology|March 20, 2010
Regression of advanced rat and human gliomas by local or systemic treatment with oncolytic parvovirus H-1 in rat modelsKarsten Geletneky, Irina Kiprianova, Ali Ayache, et al.Neuro-Oncology|November 9, 2012
Standards of care for treatment of recurrent glioblastoma--are we there yet?Michael Weller, Timothy Cloughesy, James R Perry, et al.Pageof 316